🇺🇸 FDA

Company profile · Sponsor

Changhai

Changhai Hospital

C82ECA5 · NMPA pharma CN
Pipeline
1
Drugs
0
Patents
0

Quick answer

Changhai (C82ECA5) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C82ECA5
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (1)

Search pipeline →

  1. serplulimab、bevacizumab

    Changhai

    Rectal Cancer

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Changhai?

Changhai (C82ECA5) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Changhai sponsor?

We track 1 ClinicalTrials.gov-linked program for Changhai, including serplulimab、bevacizumab. Open each program for phase, modality, NCT IDs, and indication details.

Where does Changhai company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.